The 5 key players our Family Planning Products report profiles, and other companies free public records show in this market.
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Bayer AG |
bayer.com (opens in a new tab) | 1,320 reports |
| 2 | Organon | — | 99 reports |
| 3 | Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 4 | Mylan N.V. | — | 132 reports |
| 5 | DKT International | — | 33 reports |
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| Barr | |
Glenmark Pharmaceuticals |
|
| Novast Laboratories | |
| Lupin Ltd |
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
One report for each place. Each tile opens that place's report.
Compare all 33 places for Family Planning Products, with active trials
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.